Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000409532 | SCV000485895 | likely pathogenic | Cohen syndrome | 2016-02-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000409532 | SCV001585869 | pathogenic | Cohen syndrome | 2023-02-21 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 51 of the VPS13B gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Cohen syndrome (PMID: 15154116, 19190672). ClinVar contains an entry for this variant (Variation ID: 370547). Studies have shown that disruption of this splice site results in a 16-bp deletion and introduces a premature termination codon (PMID: 15154116, 19190672). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000409532 | SCV002583761 | pathogenic | Cohen syndrome | 2022-07-20 | criteria provided, single submitter | clinical testing | PVS1, PM2, PM3 |